Cancer treatment may be missing one of the body’s most important biological signals: circadian rhythm. In this conversation, sleep neurologist Dr. Anne Marie Morse explains how sleep timing, inflammation, immune function, and wearable data could fundamentally reshape cancer care. Emerging research suggests the timing of immunotherapy, chemotherapy, and even sleep disruption itself may influence treatment response, survival, and recurrence risk. The discussion explores chronotherapy, circadian genes, microbiome interactions, and how AI-driven analytics may help clinicians move beyond episodic care toward continuous, personalized monitoring.
Ireland